U.S. Oil and Gas Stock News

Recursion Pharmaceuticals (RXRX) just posted another heavily loss making quarter, with Q3 FY 2025 revenue of US$5.2 million against a net loss of US$162.3 million and basic EPS of a US$0.36 loss. The company has seen quarterly revenue move between US$26.1 million in Q3 FY 2024 and US$4.5 million in Q4 FY 2024, while quarterly EPS has ranged from a US$0.34 loss to a US$0.53 loss over that period. This underscores a business that is still in investment mode rather than profit harvesting. For...

F5 (NasdaqGS:FFIV) and Scality have expanded their partnership to offer integrated data delivery and security solutions for AI and analytics workloads. The collaboration focuses on secure, scalable and high performance data access across cloud and hybrid environments. The move targets enterprises that need to manage, move and protect large volumes of data to support AI driven initiatives. For investors watching F5, the timing of this partnership comes as the stock trades around $272.03,...

If you are looking at Verra Mobility and wondering whether the current share price reflects its true worth, this article will walk you through how that value stacks up against several common yardsticks. The stock closed at US$18.71 recently, with returns of 2.4% over 7 days, a 12.2% decline over 30 days, a 16.2% decline year to date and a 28.5% decline over 1 year, while the 3 year and 5 year returns sit at 8.6% and 34.7% respectively. Recent coverage around Verra Mobility has centered on...

Latest FY 2025 earnings snapshot Atlas Energy Solutions (AESI) has just posted FY 2025 numbers that put the recent reset in profitability front and center, with Q4 revenue at US$249.43 million and a basic EPS loss of US$0.18, alongside trailing 12 month revenue of about US$1.10 billion and a basic EPS loss of US$0.41. Over the last six reported quarters, the company has seen quarterly revenue move between US$259.61 million and US$304.43 million while basic EPS has swung from a profit of...

Frontier Group Holdings (ULCC) has drawn fresh attention after filing a US$12.25 million shelf registration for 2,290,108 common shares tied to an ESOP offering, shortly after reporting a full year 2025 net loss. See our latest analysis for Frontier Group Holdings. The share price has moved sharply around these updates, with a 1-day share price return of a 4.92% decline and a 7-day share price return of a 13.27% decline. Over a longer period, the 90-day share price return is a 4.5% gain,...

In the past quarter, Gladstone Land Corporation reported fourth-quarter 2025 sales of US$41.45 million and net income of US$4.21 million, alongside full-year 2025 revenue of US$88.34 million and net income of US$13.53 million. The sharp year-over-year improvement in quarterly sales and earnings contrasts with softer full-year sales, highlighting how recent operational performance may be shifting for this farmland-focused REIT. Next, we’ll consider how this strong quarterly earnings growth,...

Recent performance snapshot Bel Fuse (BELF.A) has drawn fresh attention after a strong recent run, with the share price showing a 19% gain over the past month and a 67% move in the past 3 months. See our latest analysis for Bel Fuse. The recent momentum is building rather than fading, with a 30 day share price return of 19.2% and a 90 day share price return of 67%, alongside a 1 year total shareholder return of 161.2%. If Bel Fuse’s run has you thinking about where else strong trends might...

Digital Turbine, Inc. recently appointed Ben John, a veteran ad-tech and AI leader formerly at Microsoft and Xandr, as Chief Technology Officer to oversee global engineering, product architecture, data-centric scaling, and AI-driven development. This move comes alongside strong year-over-year revenue and EBITDA growth linked to international expansion and AI integration, highlighting management’s focus on turning technical capabilities into operational efficiency and business outcomes. We’ll...

Hims & Hers Health (HIMS) has capped FY 2025 with fourth quarter revenue of US$617.8 million and basic EPS of US$0.09, rounding out a year in which its trailing twelve month revenue reached about US$2.3 billion and basic EPS came in at roughly US$0.57. Over recent periods the company has seen revenue move from US$481.1 million in Q4 2024 to US$617.8 million in Q4 2025, while quarterly basic EPS shifted from US$0.12 a year ago to US$0.09 most recently. This has set up a results season where...

If you are wondering whether PACCAR's current share price reflects its underlying worth, this article walks through the key numbers that matter for valuation. PACCAR's stock recently closed at US$126.25, with returns of 3.5% over the past 30 days, 13.2% year to date, and 21.5% over the last year. The 7 day return sits at a 0.2% decline and the 3 year and 5 year returns are 95.3% and 142.0% respectively. Recent news around PACCAR has focused on its position as a major commercial vehicle...

Keurig Dr Pepper (KDP) has wrapped up FY 2025 with fourth quarter revenue of US$4.5 billion and basic EPS of US$0.26, setting the tone for how investors assess the full year. The company has seen quarterly revenue move from US$4.1 billion in Q4 2024 to US$4.5 billion in Q4 2025, while quarterly EPS shifted from a loss of US$0.11 to EPS of US$0.26 over the same period, against a trailing twelve month EPS of US$1.53. With trailing net margin at 12.5% and earnings growth highlighted over the...

In February 2026, Gentherm reported fourth‑quarter 2025 earnings showing net income falling to US$2.99 million from US$15.32 million a year earlier, while quarterly revenue of about US$382.79 million came in ahead of expectations. Alongside weaker profitability, Gentherm issued product revenue guidance of US$1.5 billion to US$1.6 billion for 2026 and US$1.7 billion for 2027, highlighting its ambition to grow beyond automotive into medical and other precision thermal applications. We’ll now...

Twist Bioscience, NasdaqGS:TWST, has entered a co exclusive licensing agreement with Invenra Inc. for Invenra's B Body bispecific antibody platform. The deal expands Twist's antibody discovery services and includes an equity investment and licensing terms that share economics between the two companies. This move adds bispecific antibody capabilities to Twist's existing biologics discovery tools, broadening the range of programs it can support for biotech and pharma customers. Twist...

If you are wondering whether Danaos is still good value after its recent run, you are in the right place. This article focuses squarely on what you are paying for each dollar of the business. The stock last closed at US$111.57, with returns of 4.0% over 7 days, 10.8% over 30 days, 17.1% year to date, 41.5% over 1 year and 116.4% over 3 years. These figures naturally raise questions about how much upside or risk is now priced in. Recent coverage of Danaos has highlighted its role in the...

Concentra Group Holdings Parent: Recent Moves In Context With no single headline event driving attention to Concentra Group Holdings Parent (CON), investors are focusing on how its recent share performance and financial profile fit into the occupational health services story. See our latest analysis for Concentra Group Holdings Parent. At a share price of $23.41, Concentra Group Holdings Parent has paired a 1 month share price return of 8.63% with a year to date share price return of 20.61%...

If you are wondering whether Regal Rexnord’s current share price really reflects what the business is worth, you are not alone. This article is built to help you assess that question clearly. With the stock at US$223.69 and returns of 2.1% over 7 days, 43.3% over 30 days, 53.1% year to date and 69.7% over 1 year, many investors are asking what is already priced in and what might still be on the table in terms of risk and reward. These moves sit against a backdrop where Regal Rexnord...

Analysts are flagging anticipated revenue declines for Fortive, citing softer demand and slower organic growth expectations. This shift in sentiment follows previously solid quarterly results and points to a possible inflection in the company’s operational outlook. The change comes as investors reassess Fortive’s near term growth profile beyond recent share price moves. For investors watching Fortive, ticker NYSE:FTV, the backdrop is a mix of steady share performance and growing questions...

Array Digital Infrastructure (NYSE:AD) has completed a transformation by selling its wireless operations and related spectrum assets. The company transferred spectrum holdings to major carriers, including T-Mobile and AT&T, and repositioned itself as a focused tower operator. Array Digital Infrastructure secured new long term Master License Agreements with top telecom companies for tower usage. The company distributed special dividends and outlined plans to invest further in its...

SI-BONE (SIBN) has wrapped up FY 2025 with Q4 revenue of about US$56.4 million and a basic EPS loss of US$0.04, alongside a trailing twelve month revenue base of roughly US$200.9 million and a TTM EPS loss of US$0.44. Over the past six quarters, revenue has moved from US$40.3 million in Q3 2024 to US$56.4 million in Q4 2025. Over the same period, quarterly basic EPS has ranged from a loss of US$0.16 in Q3 2024 to a loss of US$0.04 in the latest quarter, presenting a picture of expanding scale...

Dillard's (DDS) closed out FY 2026 with fourth quarter revenue of US$1,989.4 million and basic EPS of US$13.06, alongside net income of US$203.7 million. Earlier quarters showed revenue between US$1,490.97 million and US$1,546.97 million and EPS ranging from US$4.66 to US$10.39. Over the past year, the company reported trailing twelve month revenue of US$6.6 billion with basic EPS of US$36.32 and net income of US$570.2 million. These figures may prompt investors to focus closely on how...

Constellation Energy (CEG) has wrapped up FY 2025 with Q4 revenue of US$6.1b, Basic EPS of US$1.38 and net income of US$432m, putting a concrete set of numbers behind the recent share price of US$312.64. The company has seen quarterly revenue range between US$6.1b and US$6.8b across FY 2025, while Basic EPS moved from US$0.38 in Q1 to US$2.97 in Q3 before landing at US$1.38 in Q4, giving investors a clear view of how profit per share has shifted through the year. With trailing 12 month net...

Bank of Hawaii (NYSE:BOH) has announced that its CEO plans to retire at the end of March 2026. A board member recently executed a substantial sale of Bank of Hawaii shares. These leadership and ownership changes come as the stock last closed at $76.83. For investors watching Bank of Hawaii, the combination of a planned CEO retirement and a large board member share sale puts the focus squarely on governance and continuity. NYSE:BOH last closed at $76.83, with the stock showing returns of...

Vaxcyte (NasdaqGS:PCVX) has launched a comprehensive Phase 3 adult clinical program for its VAX-31 pneumococcal conjugate vaccine. The company has completed enrollment in a Phase 2 study of VAX-31 in infants. Vaxcyte is preparing to advance a separate vaccine candidate targeting Group A Streptococcus. These moves follow FDA alignment and an expanded Breakthrough Therapy designation for VAX-31. Vaxcyte, trading at about $61.35, is moving into a more mature stage of its pipeline, with VAX-31...

If you are wondering whether Primo Brands at around US$19.36 is a bargain or a value trap, you are not alone. This article is designed to help you frame that question clearly. The stock has seen mixed returns, with a 5.9% move over the last 7 days, 0.5% over 30 days, 19.6% year to date, a 41.6% decline over 1 year, and gains of 36.6% and 48.2% over 3 and 5 years respectively. These figures can change how investors think about both upside and risk. Recent news coverage around Primo Brands has...